60
Participants
Start Date
June 1, 2020
Primary Completion Date
February 1, 2021
Study Completion Date
February 5, 2021
Ivabradine Oral Tablet
Ivabradine 5 mg twice daily and doses (2.5, 5, 7.5 mg) were to be adjusted upwards or downwards at every visit according to HR at rest and tolerability plus their standard treatment.
Blacebo plus standard treatment
Blacebo plus standard treatment
Tanta University Hospital, Tanta
Damanhour University
OTHER